Article
A mutation in the propeptide of Factor IX leads to warfarin sensitivity by a novel mechanism.
The Journal of clinical investigation - 1 Oct 1996
Chu K, Wu S M, Stanley T, Stafford D W, High K A
Abstract excerpt
The propeptide sequences of the vitamin K-dependent clotting factors serve as a recognition site for the enzyme gamma-glutamylcarboxylase, which catalyzes the carboxylation of glutamic acid residues at the NH2 terminus of the mature protein. We describe a mutation in the propeptide of Factor IX that results in warfarin sensitivity because of reduced affinity of the carboxylase for the Factor IX precursor. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
